机译:肠溶肠道植物预防和维护儿童克罗恩病的缓解和维持
Childrens Ctr Digest Healthcare 993-D Johnson Ferry Rd NE Suite 440 Atlanta GA 30342 USA;
Sapienza Univ Rome Dept Pediat Gastroenterol &
Liver Unit Rome Italy;
Minnesota Gastroenterol PA St Paul MN USA;
Univ Pediat Associates Inc Digest Dis &
Nutr Ctr Buffalo NY USA;
Western Univ Childrens Hosp Western Ontario Schulich Sch Med Dept Pediat London ON Canada;
Inst Pomn Ctr Zdrowia Dziecka Dept Gastroenterol Hepatol &
Feeding Disorders Warsaw Poland;
Ludwig Maximilians Univ Munchen Dr von Hauner Childrens Hosp Dept Pediat Gastroenterol Munich;
Meyer Childrens Hosp Dept Gastroenterol &
Nutr Florence Italy;
AstraZeneca Gothenburg Molndal Sweden;
AstraZeneca Gothenburg Molndal Sweden;
Cortisol; inflammatory bowel diseases; pediatric Crohn's disease; pituitary- adrenal system;
机译:肠溶肠道植物预防和维护儿童克罗恩病的缓解和维持
机译:克罗恩病缓解期患者使用布地奈德6 mg维持治疗与每天9 mg的维持治疗。
机译:梅萨明胺,磺基碱,皮质类固醇和蛋白质诱导酵母病诱导的比较效果:贝叶斯网络荟萃分析
机译:克罗恩疾病中诱导缓解的新概念:抗白细胞介素-2-受体抗体和霉酚酸酯
机译:药理剂对克罗恩病减产和维持的疗效
机译:布地奈德用于克罗恩病的诱导和维持缓解:Cochrane合作的系统评价和荟萃分析
机译:低剂量口服pH调节释放的布地奈德可维持 类固醇诱导的克罗恩病缓解